JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES) ›› 2015, Vol. 53 ›› Issue (6): 28-32.doi: 10.6040/j.issn.1671-7554.0.2014.853

Previous Articles     Next Articles

Impacts of Simvastatin on DNA methyltransferase of cell line NB4 in acute myeloid leukemia

YANG Juan1, QIU Zongjian2, SONG Qiang1   

  1. 1. Department of Hematology, Qilu Hospital of Shandong University, Jinan 250012, Shandong, China;
    2. Department of Hematology, Union Hospital Affiliated to Fujian Medical University, Fuzhou 350009, Fujian, China
  • Received:2014-11-21 Revised:2015-02-28 Online:2015-06-10 Published:2015-06-10

PDF (PC)

149

Abstract: Objective To explore the impacts of Simvastatin (SIM) on DNA methyltransferase (DNMT) of cell line NB4 in acute myeloid leukemia (AML) and to investigate the possible mechanism. Methods NB4 cells were treated with different concentrations of SIM (final concentration 0, 5, 10 and 15 μmol/L). DNMT activities were detected by DNMT activity/inhibition assay. The expressions of DNMT1, DNMT3A and P53 mRNA were determined by quantitative real-time polymerase chain reaction (qRT-PCR). The expression of DNMT1, DNMT3A and DNMT3B protein levels were analyzed by Western blotting. The apoptotic rate was measured by flow cytometry. Results The DNMT activity/inhibition assay showed a dose-dependent downregulation of DNMT activities after SIM treatment (P<0.05). The expression levels of DNMT1, DNMT3A mRNA and protein were downregulated while P53 mRNA were upregulated with the increase of SIM concentration (P<0.05). DNMT3B protein level did not change significantly (P>0.05). SIM induced NB4 cell apoptosis. Conclusion Simvastatin can downregulate the DNMT activities and expression levels in AML cell line NB4 and promote cell apopotosis, which may act as a potential DNA-hypomethylating agent for AML.

Key words: Demethylation, NB4 cell line, DNA methyltransferase, Simvastatin, Acute myeloid leukemia

CLC Number: 

  • R551.3
[1] Lee RC, Feinbuim RL, Ambros V. The C.elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14[J]. Cell, 1993, 75(5):843-854.
[2] Forrester JS, Libby P. The inflammation hypothesis and its potential relevance to statin therapy[J]. Am J Cardiol, 2007, 99(5):732-738.
[3] Campese VM, Hadaya B, Chiu J. HMG-CoA reductase inhibitors and the kidney[J]. Curr Hypertens Rep, 2005, 7(5):337-342.
[4] Katz MS. Therapy insight:potential of statins for cancer chemoprevention and therapy[J]. Nat Clin Pract Oncol, 2005, 2(2):82-89.
[5] Dimitorulakos J, Thai S, Wasfy GH, et al. Lovastatin induces a pronounced differentiation response in acute myeloid leukemias[J]. Leuk LymPhoma, 2000, 40(1):167- 178.
[6] Liudmila LL, Jacobs RJ, Voorneveld PW, et al. Statins augment the chemosensitivity of colorectal cancer cells inducing epigenetic reprogramming and reducing colorectal cancer cell 'stemness' via the bone morphogenetic protein pathway[J]. Gut, 2011, 60:1544-1553.
[7] 寿倍明, 陈宝安, 刘德龙. 去甲基化在白血病上的研究进展[J]. 中国实验血液学杂志, 2008, 16(5):1247-1250. SHOU Beiming, CHEN Baoan, LIU Delong. Advance of study on demethylation in leukemia[J]. J Exp Hematol, 2008, 16(5):1247-1250.
[8] Di Ruscio A, Ebralidze AK, Benoukraf T, et al. DNMT1-interacting RNAs block gene specific DNA methylation[J]. Nature, 2013, 503(7476):371-376.
[9] Poynter JN, Gruber SB, Higgins PD, et al. Statins and the risk of colorectal cancer[J]. N Engl J Med, 2005, 352(21):2184-2192.
[10] Ishikawa S, Hayashi H, Kinoshita K, et al. Statins inhibit tumor progression via an enhancer of zeste homolog 2-mediated epigenetic alteration in colorectal cancer[J]. Int J Cancer, 2014, 135(11):2528-2536.
[11] Svedruzic ZM, Reich NO. The mechanism of target base attack in DNA cytosine carbon 5 methylation[J]. Biochemistry, 2004, 43(36):11460-11473.
[12] Pradhan S, Esteve PO. Mammalian DNA (cytosine-5) methyltransferases and their expression[J]. Clin Immunl, 2003, 109(1):6-16.
[13] Oka M, Meacham AM, Hamazaki T, et al. De novo DNA methyltransferases Dnmt3a and Dnmt3b primarily mediate the cytotoxic effect of 5-aza-2'-deoxycytidine[J]. Oncogene, 2005, 24(19):3091-3099.
[14] Li HY, Appelbaum FR, Willman CL, et al. Cholesterol-modulating agents kill acute myeloid leukemia cells and sensitize them to therapeutics by blocking adaptive cholesterol responses[J]. Blood, 2003, 101(9):3628-3634.
[1] GAO Xiu-Rui, ZANG Heng-Chang. In vitro release of compound niacin extended-release and simvastatin immediaterelease double-layer tablets [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2209, 47(6): 109-113.
[2] SONG Yu, MAO Yang, LIU Qingmei, QIAO Lei, TIE Yuanyuan, LU Lu, ZHANG Lei. Effect of Tongxinluo on three-dimensional strain of atherosclerotic vulnerable plaque in rabbits [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2017, 55(5): 1-7.
[3] WANG Cong, SUN Shuzhen, ZHEN Junhui, LI Qian, XU Yihuai. Role of CXCL16 in mice with adriamycin induced nephropathy and the protective effects of simvastatin [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2015, 53(9): 24-29.
[4] LIN Jinxiu, SUN Dongsheng, ZHENG Xiao, YIN Dechao, LI Ye, ZHANG Lei. Enhancement of tendon-bone healing by topical use of simvastatin after ACL reconstruction [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2015, 53(3): 27-31.
[5] LIU Jun1, ZHU Tian-rui2, LI Xiao-hong2. Effects of simvastatin on RhoA/ROCK pathway and secretion of Aβ42 in β-secretase transferred HEK293 cells [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2013, 51(10): 1-4.
[6] DING Qi-cui1, WANG Wei1, WANG Yong-bin1, CHEN Xu-dong2, WU Qian1. Effect of simvastatin on lung apoptotic factor in chronic
obstructive pulmonary disease rat models [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2012, 50(6): 65-.
[7] YIN Dong-mei1, XU Hong-zhi1, ZHANG Jing-yao1, SUI Xiao-hui1, CUI Bin2, MA Chun-yan2, ZHEN Chang-qing1. Changes and clinical significances of CD4+T cell subsets in aplastic anemia,
myelodysplastic syndromes and acute myeloid leukemia patients [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2012, 50(3): 66-70.
[8] KONG Hai-li, MA Dao-xin， ZHANG Jingjing, WANG Hui-jun, LIU Chuan-fang. Expression and significance of PDCD4 and TGF-β1 in patients with acute myeloid leukemia [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2011, 49(6): 110-114.
[9] CHEN Xudong， WANG Wei， WANG Yongbin. Effect of simvastatin on inflimmation in chronic obstructive  pulmonary disease rat model [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2010, 48(4): 36-.
[10] . Effects of Simvastatin on the levels of plasma Fas／Apo1 and inflammatory factors in patients with chronic obstructive pulmonary disease [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2009, 47(8): 75-78.
[11] GAO Xiu-Rui, ZANG Heng-Chang. In vitro release of compound niacin extended-release and simvastatin immediaterelease double-layer tablets [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2009, 47(6): 109-.
[12] DING Yan, WEI Xin-Bing, HAN Yu-Xia, DING Hua. Effect of Simvastatin on expression of GluR2  in the hippocampus of rats injured by Glutamate [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2009, 47(5): 38-41.
[13] DOU Shanshan1,　DENG Jingti1,　JI Ran1,　HU Yanlai1, ZHANG Weihong2,　ZHANG Liping1
. Inhibitory effect of simvastatin on expression of Cytokine TNFα,
IL6 and uPA/uPAR secreted by HUVECs [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2009, 47(04): 1-4.
[14] ZHANG Li1,2, LIU Tongbao1, YIN Chenghua1,2
. reactive protein levels in patients with acute coronary syndrome [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2009, 47(03): 71-73.
[15] LIU Tong-tao,YU Qing-xia,TIAN Qing-yin,SUN Chun-li,LI Bo-qin. Medication intervention on heme oxygenase/carbon monoxide and nitric oxide synthase/nitric oxide systems in the atherosclerosis model of rabbits [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2008, 46(6): 566-570.
Viewed
Full text


Abstract

Cited
  Shared   
  Discussed   
No Suggested Reading articles found!
Copyright 2018 © Editorial office of Journal of Shandong University (Health Sciences)
Supported by Beijing Magtech Co.Ltd